Literature DB >> 2570250

Bacteriotherapy for Clostridium difficile diarrhoea.

D V Seal, S P Borriello, M Piper.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2570250     DOI： 10.1016/s0140-6736(89)90674-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities.

Authors:  Kenneth Timmis; James Kenneth Timmis; Harald Brüssow; Luis Ángel Fernández
Journal:  Microb Biotechnol       Date:  2019-01       Impact factor: 5.813

Review 2.  Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes.

Authors:  Willem M de Vos
Journal:  Microb Biotechnol       Date:  2013-04-10       Impact factor: 5.813
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.